Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
A multicenter, randomised, double-blind, placebo-controlled, parallel-group proof- of-concept study to assess the efficacy, safety and tolerability of two single i.v. infusions of AIN457 10 mg/kg (anti-IL17 monoclonal antibody) in patients with moderate to severe active Crohn’s disease https://www.kusajili.fr:443/Trial/JgyvGT5azECDjwzXvmB0rw%24a-multicenter-randomised-double-blind-placebo-controlled-parallel-group-proof--of-concept-study-to-assess-the-efficacy-safety-a
I have read and accept the terms of use of the site and the Privacy Policy
Send your message